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Summary
The C-terminal domain (CTD) of RNA polymerase II
(RNAPII) is an essential component of transcriptional
regulation and RNA processing of protein-coding
genes. A large body of data also implicates the CTD in
the transcription and processing of RNAPII-mediated
small nuclear RNAs (snRNAs). However, the identity
of the complex (or complexes) that associates with
the CTD and mediates the processing of snRNAs has
remained elusive. Here, we describe an RNA polymer-
ase II complex that contains at least 12 novel sub-
units, termed the Integrator, in addition to core
RNAPII subunits. Two of the Integrator subunits dis-
play similarities to the subunits of the cleavage and
polyadenylation specificity factor (CPSF) complex.
We show that Integrator is recruited to the U1 and
U2 snRNA genes and mediates the snRNAs’ 3 end
processing. The Integrator complex is evolutionarily
conserved in metazoans and directly interacts with
the C-terminal domain of the RNA polymerase II
largest subunit.
Introduction
Deleted in split hand/split foot 1 (DSS1), the product of
a candidate gene for split hand/split foot, was initially
identified as a small w10 kDa acidic protein that could
directly interact with the C-terminal domain of the
BRCA2 protein (Marston et al., 1999). A more recent
study examining the crystal structure of BRCA2 C-ter-
minal domain with DSS1 revealed the importance of
DSS1 in endowing the C terminus of BRCA2 with pro-
tein folds reminiscent of single-stranded nucleotide
binding proteins (Yang et al., 2002).
Most of the current data suggest that BRCA2 serves*Correspondence: shiekhattar@wistar.upenn.eduas a tumor suppressor and indicate a role in DNA repair.
A number of laboratories have reported that the BRCA2
protein interacts with RAD51 (Chen et al., 1998; Mar-
morstein et al., 1998; Mizuta et al., 1997; Wong et al.,
1997). RAD51 is the hallmark of homologous recombi-
nation, suggesting a function for BRCA2 in recombina-
tion or double-strand-break DNA repair. These results
were strengthened by reports showing that targeted
disruption of BRCA2 resulted in sensitivity to ionizing
radiation (Sharan et al., 1997), ultraviolet light, and
methyl methanesulfonate (MMS) (Patel et al., 1998).
Surprisingly, a number of studies have also reported
the intimate association of yeast and human DSS1 pro-
teins with the 19S subcomplex of the proteasome,
pointing to DSS1 as an evolutionarily conserved sub-
unit of the proteasome complex (Funakoshi et al., 2004;
Sone et al., 2004). Interestingly, both DSS1 and the 19S
proteasome have been shown to play roles in the path-
ways responsive to DNA damage (Krogan et al., 2004).
This is of particular interest since the BRCA2/DSS1
complex was also suggested to play a role in homol-
ogy-directed DNA repair (Kojic et al., 2003, 2005).
To elucidate the molecular mechanism by which
DSS1 induces its functional effects, we isolated the
DSS1-containing complexes from HEK293-derived cell
lines stably expressing Flag-DSS1 and identified its
components by mass spectrometry. Here we show that
DSS1 is a component of multiple distinct complexes.
These complexes include the 19S proteasome, the
BRCA2/RAD51 complex, and a novel multiprotein com-
plex termed Integrator. The Integrator complex is asso-
ciated with the C-terminal domain (CTD) of RNA poly-
merase II (RNAPII) largest subunit and mediates the
3# end processing of small nuclear RNAs U1 and U2.
Small nuclear RNAs (snRNAs) are components of the
spliceosome, a complex assembly of ribonucleopar-
ticles involved in pre-mRNA processing (Jurica and
Moore, 2003). The majority of snRNAs (i.e., U1 to U5)
are transcribed by RNAPII to yield short nonpolyade-
nylated 3#-extended precursors (Eliceiri and Sayave-
dra, 1976; Wieben et al., 1985). These precursors are
then exported to the cytoplasm for further 3# trimming
and incorporation into the small nuclear ribonucleopar-
ticles (snRNPs) (Kleinschmidt and Pederson, 1987;
Uguen and Murphy, 2003). The formation of proper
snRNA precursors depends on a cis-acting sequence,
named the 3# box, located 9–19 nucleotides down-
stream of the 3# end of the mature snRNA (You et al.,
1985; Hernandez, 1985; Uguen and Murphy, 2003) and
the presence of a snRNA-compatible promoter at the
5# end of the gene (de Vegvar et al., 1986; Hernandez
and Weiner, 1986). Furthermore, the CTD of the largest
subunit of RNAPII has been shown to play a crucial role
in snRNA 3# end processing (Jacobs et al., 2004; Med-
lin et al., 2003; Uguen and Murphy, 2003).
Our findings not only point to the immense intricacy
of DSS1-containing complexes but also illuminate a
novel RNAPII-containing multiprotein complex rivaling
the Mediator in its complexity. Moreover, by defining
Cell
266Figure 1. Isolation of DSS1-Associated Com-
plexes
(A) Purification scheme. DSS1-associated
polypeptides were affinity purified from
nuclear extract of Flag-DSS1-expressing
HEK293 cells using M2 anti-Flag beads.
After washing, bound polypeptides were
eluted by 400 g/ml Flag peptide. Flag-
eluted peptides were fractionated on a Su-
perose 6 gel filtration column in the presence
of 0.5 M KCl.
(B) Western blot analysis. Gel filtration frac-
tions were separated through a SDS-poly-
acrylamide (4%–20%) gel, transferred to a
PVDF membrane, and immunoblotted using
the different antibodies indicated on the left
of the figure. Fraction numbers are indicated
on top of the gel.the Integrator complex, we have uncovered the elusive
complex responsive for the 3# end processing of RNAPII-
mediated snRNAs.
Results
The 19S Proteasome Is the Predominant
DSS1-Containing Complex
To determine the polypeptide composition of the DSS1-
containing complex (or complexes), we developed
HEK293-derived cell lines stably expressing a Flag-
tagged DSS1 and purified DSS1-associated proteins by
anti-Flag affinity purification (Figure 1A). To determine
the identity of the DSS1-associated polypeptides, the
Flag affinity eluate was separated on a polyacrylamide
gel, bands were stained with colloidal blue, and indi-
vidual polypeptides were excised from the gel and sub-
jected to mass spectrometric analysis. This resulted in
the identification of the 19S proteasome subunits as
the main component of DSS1-associated polypeptides
(see Table S1 in the Supplemental Data available with
this article online). In addition, we obtained peptide se-
quences corresponding to BRCA2, RNA polymerase II
(RNAPII), and a number of uncharacterized human
open reading frames. Surprisingly, although the novel
polypeptides do not display any homology to yeast
genes, nearly all of the new DSS1-associated polypep-
tides have homologs in metazoans (Table S2).
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iTo establish the molecular mass of different DSS1-
ontaining complexes, we fractionated the Flag-DSS1
luate by gel filtration chromatography using 500 mM
Cl. Analysis of gel filtration fractions by SDS-PAGE
ollowed by Western blot analysis revealed the coelu-
ion of BRCA2, RNAPII, and the novel subunits de-
cribed in Table S1 in a large complex of about 2 MDa,
hile the components of the 19S proteasome eluted
ith a smaller molecular mass ofw700 kDa (Figure 1B).
aken together, these results demonstrate the occur-
ence of DSS1 as a component of distinct multiprotein
omplexes that could be partially resolved by gel filtra-
ion chromatography.
SS1 Associates with a Set of Novel Polypeptides
esides the subunits of the 19S proteasome and
RCA2, the novel polypeptides associated with DSS1
ould be classified in two categories: a set of polypep-
ides that were found to be stably associated with
NAPII that were named Ints (Integrator, for integrating
he CTD of RNAPII largest subunit with the 3# end pro-
essing of small nuclear RNAs U1 and U2) and two
olypeptides (KIAA1932 and Sac3 homology domain 1)
hat contain domains predictive of a function in RNA
ransport but were not found to be in a stable complex
ith RNAPII (Table S1). Most Integrator polypeptides
id not show significant homology with known proteins
n the database. However, a closer examination of Int6,
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267Figure 2. The Integrator Complex Purification
(A) Purification scheme and composition of the Integrator complex. Int10-associated polypeptides were Flag affinity purified from nuclear
extracts of Flag-Int10-expressing HEK293 cells using M2 anti-Flag beads. The silver staining of the Integrator subunits after SDS-PAGE (4%–
12%) electrophoresis is shown on the right. Polypeptides Flag affinity purified from nuclear extracts of KIAA1932-expressing HEK293 cells
using the same protocol are shown as a control. Molecular marker proteins and Integrator subunits as identified by mass spectrometry
are indicated.
(B) Int11-associated polypeptides were purified as in (A), resolved by SDS-PAGE (4%–12%), and silver stained. The presence of other Integra-
tor subunits was assessed by Western blot (right panel) using the indicated antibodies.
(C) Superose 6 gel filtration fractionation of the Flag-Int11-associated polypeptides. Fractions were resolved by SDS-PAGE (4%–12%) and
analyzed by silver staining. Fraction numbers are indicated on top of the blot.
(D) Western blot analysis of the gel filtration fractions. Fractions were resolved by SDS-PAGE (4%–12%), transferred to a PVDF membrane,
and blotted with the antibodies indicated on the left of the figure. Fraction numbers are indicated on top of the blot.
Cell
268Figure 3. The Integrator Complex Interacts with the CTD of the RNA Polymerase II
(A) 8WG16 CTD-specific antibodies are able to displace the Integrator complex from RNA polymerase II. Left panel, purification scheme; right
panel, Western blot analysis. The presence of RNA polymerase II and Flag-Int11 was tested in the input and flowthrough of an 8WG16 affinity
column by Western blot analysis.
(B) Purification of RNA polymerase II CTD-associated polypeptides. HeLa nuclear extracts were fractionated on a phosphocellulose column.
The 0.5 M and 1 M KCl elution fractions were dialyzed and loaded onto a GST-CTD column. Bound polypeptides were eluted, resolved by
SDS-PAGE (4%–20%), and silver stained. Left panel, purification scheme; right panel, silver stain of the GST-CTD eluate. The names of the
polypeptides, as identified by microsequencing, are indicated.
(C) Comparison between the Flag-Int11- and GST-CTD-associated polypeptides. Proteins were resolved by SDS-PAGE (4%–12%) and silver
stained.Int7, and Int12 domain structure revealed the presence
of a von Willebrand factor type A (vWA), an ARM repeat,
and a PHD domain, respectively. Of notable exception
were Int11 and Int9, which displayed sequence homol-
ogy to the subunits of the cleavage and polyadenyla-
tion specificity factor CPSF-73 and CPSF-100, respec-
tively (Dominski et al., 2005). Importantly, Int11 contains
the putative catalytic β-lactamase domain predicted to
function as an RNA-specific endonuclease (Callebaut
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dt al., 2002). While nearly all Integrator subunits have
omologs in metazoans (Table S2), we could not detect
ny homology for Integrator polypeptides in fungi.
dentification of the Integrator Complex
s an Evolutionarily Conserved RNA
olymerase II-Containing Complex
o begin deciphering the polypeptide composition of
ifferent DSS1-containing complexes, we developed
A Novel RNA Polymerase II Complex
269Figure 4. The Integrator-RNAPII Complex Mediates RNAPII-Dependent Transcription
(A) The Integrator complex is competent for transcription. Reconstituted transcription assays using adenovirus late promoter were performed
with increasing amount of Integrator complex and compared with core polymerase.
(B) Diagram of a U snRNA gene. Location of the distal promoter element (DSE), proximal promoter element (PSE), and the 3# end formation
signal (3# Box) are indicated with rectangular boxes. Numbers on top of the diagram refer to the approximate position according to the
transcription start site. The two amplicons (noted A and B on the diagram) used for chromatin immunoprecipitation analysis are represented
as black bars under the diagram.
(C) The Integrator complex is present on U1 and U2 snRNA genes but absent from the GAPDH gene. Soluble chromatin from Flag-Int11
stably expressing cells was immunoprecipitated using the antibodies indicated on top of the panel. After elution and crosslinking reversal,
the presence of DNA fragments corresponding to the U1 and U2 snRNA genes (A and B) or the GAPDH gene (5#, coding sequence [cds], and
3#) was detected by PCR. IgG and 8WG16 anti-CTD (RNAPII) antibodies were used as negative and positive controls, respectively.
(D) As in (C), the presence of DNA fragments corresponding to U2 snRNA gene (fragment B) or cell-cycle-dependent histone H3 was detected
by PCR.
(E) Chromatin from Flag-Int10 (top panel) and Flag-KIAA1932 (bottom panel) stably expressing cells was immunoprecipitated using the
antibodies indicated on top of the panels. The presence of DNA fragments corresponding to the U1 and U2 snRNA gene (A and B) was
detected by PCR.
Cell
270Figure 5. The Integrator Complex Is Involved in U snRNA 3# End Processing
(A) Diagram of U snRNA probes used for ribonuclease protection assay (RPA). The structure of a U snRNA gene is displayed on top. Primary
and mature transcripts are represented as gray arrows. The RPA probe and the corresponding protected fragments for each transcript are
represented as a black arrow and two black bars, respectively.
(B) SiRNA-directed inactivation of Int11 expression. HeLa cells were transfected with luciferase or Int11 siRNAs. Seventy-two hours after
transfection, total RNA was extracted, and the expression level of Int11 and GAPDH mRNA was assessed by RT-PCR.
(C) Depletion of Int11 affects the 3# end processing of U1 and U2 snRNA. Ten micrograms of total RNA from luciferase or Int11 siRNA-treated
HeLa cells was analyzed by RPA with U1 or U2 radiolabeled RNA probe. As a control, 10 g of yeast RNA treated under the same conditions
before (Probe) or after (Probe + T1) RNase T1 treatment yielded no nonspecific fragment. The relative primary-over-mature transcript ratio is
given below each lane as determined after phosphorimager quantification.
(D and E) Same as in (B) and (C), respectively, using two different siRNAs directed against the Int1 subunit of the Integrator complex.
(F) Depletion of Int11 or Int1 has no effect on the 3# end cleavage of GAPDH mRNA. Ten micrograms of total RNA from luciferase, Int11, or
Int1 siRNA-treated HeLa cells was analyzed by RPA with U2 or GAPDH radiolabeled RNA probe. The relative primary-over-mature transcript
ratio is given below each lane as determined after phosphorimager quantification.
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271HEK293-derived stable cell lines expressing Flag-Int11,
Flag-Int10, and Flag-KIAA1932. Isolation of Flag-Int10
affinity eluate followed by mass spectrometric and
Western blot analysis of Int10-associated polypeptides
revealed the presence of RNAPII and the other afore-Figure 6. Int11 Activity Is Required for 3# End U snRNA Formation
(A) Partial amino acid alignment between Int11 and CPSF73. Conserved amino acids are indicated with a star. Amino acids in the catalytic
center are highlighted in gray. The position and nature of the substitution made in the Int11 (E203Q) mutant are indicated on the alignment.
(B) Comparison of the polypeptide composition of the Integrator complexes affinity purified from Flag-Int11 and Flag-Int11 (E203Q) cell lines.
After Flag peptide elution, the complexes were resolved by SDS-PAGE (4%–12%) and silver stained.
(C) Int11 (E203Q) mutant is still associated with the U2 snRNA gene in vivo. The presence of Flag-Int11 (E203Q) on the U2 snRNA gene was
assessed by ChIP using anti-Flag antibodies. IgG and 8WG16 anti-CTD (RNAPII) antibodies were used as negative and positive controls, re-
spectively.
(D) The E203Q mutation in the active site of Int11 prevents the proper formation of the 3# end of U1 and U2 snRNA. Ten micrograms of total
RNA from cells transfected with pFlag-CMV2 (Flag), Flag-Int11, or Flag-Int11(E203Q) expression vectors was analyzed by RPA using U1 or
U2 radiolabeled RNA probe. As a control, 10 g of yeast RNA treated under the same conditions before (Probe) or after (Probe + T1) RNase
T1 treatment yielded no nonspecific fragment. The relative primary-over-mature transcript ratio is given below each lane as determined after
phosphorimager quantification.mentioned Integrator subunits (Figure 2A and Table S1).
A similar polypeptide composition was obtained follow-
ing the analysis of Flag-Int11 (Figure 2B). In contrast,
Flag-KIAA1932 affinity eluate was devoid of RNAPII or
any Integrator subunits (Figure 2A; peptide bands at
Cell
27268, 55, and 34 kDa correspond to SKB1, α-tubulin, and
MEP50 common contaminants of Flag purification).
Moreover, despite a number of attempts and consistent
with a previous report, we were unable to detect either
Flag-DSS1 or endogenous DSS1 using Western blot
analysis (Marston et al., 1999). Furthermore, mass spec-
trometric analysis of Integrator subunits did not reveal
any sequences corresponding to the BRCA2 protein.
Next we analyzed the Flag-Int11 affinity eluate by gel
filtration. This analysis revealed the association of In-
tegrator subunits and RNAPII in a large complex peak-
ing in fractions 16 through 20, while a fraction of Flag-
Int11 eluted as a smaller complex, peaking at fraction
30, devoid of RNAPII (Figures 2C and 2D). Moreover, a
fraction of RNAPII and Flag-Int11 eluted with a molecu-
lar mass of about 700 kDa. These results indicate that,
while Integrator subunits are associated with RNAPII in
a large 2 MDa complex, a fraction of RNAPII and the
Integrator subunits (Int11 and Int9) could be resolved
from the larger complex by gel filtration.
The Integrator Complex Can Directly Associate
with the C-Terminal Domain of RNA
Polymerase II Largest Subunit
Both the yeast and the human Mediator complex asso-
ciate with the RNAPII through its C-terminal domain
(CTD), a heptapeptide repeat at the C terminus of the
largest subunit of RNAPII (Kim et al., 1994; Naar et al.,
2002). Specifically, fractionation of the yeast RNAPII-
Mediator complex through an 8WG16 affinity chroma-
tography column (antibodies raised against the CTD of
the RNAPII purified from wheat-germ extracts) resulted
in the disruption of the association of the Mediator and
the CTD of RNAPII. While RNAPII was retained on the
antibody column, Mediator was recovered in the flow-
through fraction displaced by the action of the anti-
CTD antibodies (Kim et al., 1994).
To ask whether the Integrator complex can directly
associate with the CTD, the Flag-Int11 affinity eluate
was fractionated through an 8WG16 affinity chromato-
graphy column (Figure 3A). Analysis of the anti-CTD af-
finity flowthrough fraction revealed the presence of In-
tegrator subunits, while the RNAPII was retained on the
antibody column (Figure 3A).
To directly examine the association of the Integrator
complex and the CTD, HeLa nuclear extract enriched
for the Integrator complex following phosphocellulose
(P11) chromatography (0.5 M KCl eluate) was subjected
to affinity purification by a GST-CTD column. As a con-
trol, a fraction enriched for the ARC-S/CRSP/PC2/
Mediator complex (1.0 M KCl eluate) was also analyzed
following binding to a GST-CTD column. While mass
spectrometric analysis of the CTD affinity eluate de-
rived from the 0.5 M P11 fraction revealed the associa-
tion of a subcomplex of at least six Integrator subunits
with the CTD, the eluate derived from the 1 M P11 frac-
tion contained the ARC-S subcomplex of the Mediator
complex (Figure 3B). Moreover, SDS-PAGE followed by
silver-staining analysis of Flag-Int11 affinity eluate and
Integrator subunits isolated by GST-CTD revealed a
similar polypeptide composition (Figure 3C). It is likely
that, similar to the Mediator complex, only a subcom-
plex of Integrator subunits can directly associate with
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whe CTD of RNAPII, while other subunits of the Integra-
or complex may contact the RNAPII through other
olymerase subunits (Bjorklund and Gustafsson, 2004).
he Integrator Complex Mediates RNA Polymerase
I-Dependent Transcription and Occupies the
romoter of Two Small Nuclear RNA Genes
ince the Integrator complex can be isolated as a stable
omponent of RNAPII, we asked whether the Integrator-
NAPII could mediate an RNAPII-dependent transcrip-
ion reaction in a reconstituted transcription system
sing adenovirus type 2 as the template. As Figure 4A
emonstrates, the Integrator-RNAPII complex could re-
onstitute transcription to the same levels as core
NAPII in an in vitro transcription system. However, ec-
opic expression of Integrator subunits or depletion of
ntegrator subunits using small interfering RNA (siRNA)
ransfections did not result in alteration of c-fos mRNA
evel or c-fos promoter activity during serum or EGF
nduction (data not shown). Moreover, we could not de-
ect the Integrator complex at the c-fos promoter using
hromatin immunoprecipitation (ChIP) (data not shown).
his led us to examine other genes besides mRNA-
oding genes whose expression is also mediated by
NAPII. One class of genes in which not only expres-
ion but also 3# end transcript processing is mediated
hrough RNAPII includes the snRNA genes, U1 and U2.
ndeed, the CTD of RNAPII is required for the transcrip-
ion and processing of U1 and U2 snRNAs (Uguen and
urphy, 2003). Therefore, we examined the promoter
nd coding region of U1 and U2 genes for the presence
f the Integrator complex and RNAPII using ChIP (Fig-
res 4B–4E). The ChIP signals centered on the pro-
oter and 3# regions of U1 and U2 genes were specific
nd equally strong (Figure 4C). We also compared the
ssociation of Integrator with the U2 and the high copy
umber histone H3 genes (Figure 4D). This analysis re-
ealed the specific association of Integrator with the
2 gene (Figure 4D). Moreover, comparison of stable
ell lines expressing Flag-Int10 or Flag-KIAA1932 using
lag antibody for ChIP revealed the specific associa-
ion of Integrator with U1 and U2 genes only in cells
xpressing Flag-Int10 (Figure 4E). While these results
ndicate that the Integrator-RNAPII complex is recruited
o the U1 and U2 snRNA genes, due to the low resolu-
ion of ChIP, we cannot determine with certainty
hether the Integrator is occupying the promoter, the
# region of the U1 and U2 genes, or both.
he Integrator Complex Mediates the 3 End
rocessing of U1 and U2 snRNAs
o ask whether the Integrator complex plays a role in
nRNA processing, we used RNA interference to de-
lete Int11 (the predicted catalytic engine of the Inte-
rator) or Int1 (the largest subunit of the Integrator
omplex). Processing of U1 and U2 small RNAs was
ssessed by T1 ribonuclease protection (Figure 5A).
nalysis of U1 and U2 primary transcripts after Int11
epletion (Figure 5B) revealed a pronounced accumula-
ion of the primary transcript, consistent with a defect
n the processing of the 3# end of the U1 and U2 snRNA
ranscripts (Figure 5C). Similar results were obtained
hen the Int1 subunit of the complex was depleted
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273Figure 7. Mechanistic Model Linking snRNA Transcription to 3# Box-Dependent Processing through the Integrator Complex
The Integrator complex interacts with RNA polymerase II at the promoter of snRNAs genes (1). The Integrator complex travels with the
polymerase until transcription of the 3# box (2). RNA processing occurs after Integrator interaction with the 3# box (3). Termination occurs
after release of the Integrator complex and the cleaved snRNA (4).using two different siRNAs (Figures 5D and 5E). Accu-
mulation of this transcript represents the extension of
primary transcript beyond its natural processing site lo-
cated upstream from the 3# box (Eliceiri and Sayavedra,
1976; Wieben et al., 1985). Moreover, the defect in the
3# end processing did not result in decreased levels
of mature U1 and U2 transcripts, consistent with the
reported long half-life of RNAPII-transcribed spliceoso-
mal snRNAs (U1, U2, U4, and U5) exceeding 60 hr (Fury
and Zieve, 1996). Finally, while depletion of Int11 or Int1
resulted in the accumulation of U2 primary transcript,
there was no change in the GAPDH primary transcript
(Figure 5F).
Int11 Is the Catalytic Subunit
of the Integrator Complex
To directly assess the Int11 catalytic activity in mediat-
ing the 3# end processing, we constructed HEK293-
derived stable cell lines expressing a mutant Int11
(E203Q) (Figure 6A) predicted to abrogate the catalytic
activity of the β-lactamase domain by disruption of an
ion-chelating residue in the active site of the enzyme
(Ryan et al., 2004). Isolation of the Flag-Int11 (E203Q)
complex confirmed the association of Int11 (E203Q)
with the other subunits of the Integrator and RNAPII
complex (Figure 6B). Similarly, ChIP analysis confirmed
the specific association of the Flag-Int11 (E203Q) with
both the promoter and the 3# end of U1 and U2 snRNA
genes (Figure 6C). We then analyzed the effect of Int11
(E203Q) overexpression on 3# end processing of U1
and U2 primary transcripts. Consistent with results ob-
tained following depletion of Int11, Int11 (E203Q) cell
lines displayed a pronounced defect in processing of
U1 and U2 primary transcripts (Figure 6D). Taken to-
gether, these results demonstrate a role for Int11 cata-lytic activity in the processing of U1 and U2 snRNA
genes.
Discussion
The key findings of this work are the following. First, it
reveals the identification of Integrator as a complex of
some 12 polypeptides in a stable association with
RNAPII. Second, it shows the direct association of In-
tegrator with the CTD of RNAPII, extending the role of
the CTD in targeting multiprotein complexes with roles
in transcriptional regulation and RNA processing. Third,
it identifies Int11 and Int9 as subunits with close homol-
ogy to CPSF-73, the catalytic subunit of the CPSF com-
plex, implicating a role for Integrator in RNA process-
ing. Fourth, through functional abrogation of Int11 and
Int1, it suggests a role for the Integrator complex in
mediating the 3# end processing of U1 and U2 snRNAs.
Fifth, it attests to the biochemical complexity of DSS1-
containing complexes. Our studies are consistent with
the notion that DSS1 is a component of at least three
distinct complexes. These include a DSS1/19S protea-
some, a BRCA2/DSS1 complex, and a DSS1/Integra-
tor complex.
Although the subunits of the Integrator complex are
not present in fungi, most Integrator polypeptides
display homology with uncharacterized open reading
frames in Drosophila and C. elegans. However, many
Integrator subunits display little homology with other
characterized proteins in the genome of eukaryotes. Of
exception are Int11 and Int9, which display sequence
homology with CPSF-73 and CPSF-100, the two com-
ponents of the CPSF complex. Moreover, Int6 was pre-
viously identified as DICE1, the candidate tumor sup-
pressor in non-small-cell lung carcinoma (Wieland et
Cell
274al., 2004). It was surprising to us that none of the Inte-
grator subunits had been previously identified through
genetic analyses in Drosophila or C. elegans. This may
indicate the essential requirement for Integrator poly-
peptides for viability of organisms used for such genetic
analyses. It is also intriguing that analysis of Integrator
subunits by BLAST does not reveal homologous sub-
units in yeast. It is possible that future closer examina-
tion of the yeast genome may reveal proteins with do-
main structure and function similar to the Integrator
subunits.
The Integrator-CTD interaction is reminiscent of as-
sociation of the other multiprotein complex, the Media-
tor, with the CTD of RNAPII. Indeed, similar to the Medi-
ator complex, Integrator may be recruited to the
promoter of RNAPII-dependent genes. Future studies
will reveal whether Integrator also plays roles in modu-
lation of transcriptional activation of snRNA genes. One
notable difference between the two complexes is the
presence of polypeptides with RNA-processing activity
in the Integrator complex.
The precise mechanism of U1 and U2 snRNA 3# end
processing is not understood. The 3# end processing
of U1 and U2 snRNAs in vivo depends on the presence
of a U type snRNA promoter at the 5# end of the coding
region (de Vegvar et al., 1986; Hernandez and Weiner,
1986) as well as the CTD of the RNAPII (Jacobs et al.,
2004; Medlin et al., 2003; Uguen and Murphy, 2003).
These results clearly suggest a scenario implicating a
cotranscriptional mechanism in the 3# end processing
of U1 and U2 snRNAs. This is consistent with our identi-
fication of the Integrator as the complex that may be
recruited to the promoter of snRNA genes through its
interaction with the CTD of RNAPII and mediates the
snRNAs’ 3# end processing. This contention is consis-
tent with a plausible model shown in Figure 7, repre-
senting a mechanism where Integrator is loaded on the
RNAPII at the promoter, traveling with it along the gene
and cleaving the nascent primary transcript, most likely
by recognizing the 3# box at the end of the transcript
(Figure 7). Following the cleavage of the primary tran-
script by Integrator, the newly transcribed U snRNA is
exported to the cytoplasm for 3# end trimming and in-
corporation into the snRNPs.
Experimental Procedures
Affinity Purification of Flag-Tagged Proteins
Flag-fusion-expressing plasmids and a selectable marker for puro-
mycin resistance were cotransfected in HEK293T cells. Transfected
cells were grown in presence of 5 g/ml puromycin (Sigma) for
selection. Individual colonies were isolated and screened for Flag-
fusion-protein expression. Nuclear extracts of Flag-fusion-express-
ing cells (50 mg) were incubated with 250 l of anti-Flag M2 affinity
gel (Sigma) for 2 hr at 4°C. Beads were washed with 4 × 10 ml
BC500 buffer (20 mM Tris [pH 8], 0.5 M KCl, 10% glycerol, 1 mM
EDTA, 1 mM DTT, 0.1% NP40, 0.5 mM PMSF, aprotinin, leupeptide,
and pepstatin, 1 g/ml each) and one time with 10 ml BC100 buffer
(20 mM Tris [pH 8], 0.1 M KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT,
0.1% NP40, aprotinin, leupeptide, and pepstatin, 1 g/ml each).
Bound peptides were eluted with 400 g/ml Flag peptide (Sigma)
in BC100 buffer. For size-exclusion chromatography, peptides were
loaded onto a Superose 6 HR 10/30 column equilibrated with
BC500 (Flag-DSS1) or BC300 buffer (Flag-Int11). Flow rate was
fixed at 0.35 ml/min, and 0.5 ml fractions were collected.
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Cmmunoblot Analysis
fter separation by SDS-PAGE, proteins were transferred to a
VDF membrane. Membranes were blocked with TTBS (10 mM Tris
pH 7.4], 150 mM NaCl, 0.05% Tween 20) plus 5% nonfat dry milk.
ntibodies were diluted in TTBS. Primary antibodies were detected
sing phosphatase-conjugated anti-IgG antibodies (Promega).
Anti-Int2 and anti-Int9 polyclonal antibodies were raised against
he following peptides: Int2, VDVVCLASLSDPELR; Int9, GWSLKD
NAFLDKELKE. Anti-BRCA2 monoclonal antibodies were raised
gainst the C-terminal part of BRCA2 fused to GST. Anti-RNA poly-
erase II antibodies were a kind gift of D. Reinberg. Anti-Flag M2,
WG16 ascites, and anti-RAD51 antibodies were purchased from
igma, Covance, and Upstate Biotechnology (Lake Placid, NY), re-
pectively.
lasmid Constructs
ull-length cDNAs for DSS1, Int11, Int10, and KIAA1932 were am-
lified by standard PCR techniques and cloned into a pFlag-CMV2
Sigma) vector.
For RNA probe synthesis, sequences of U1 and U2 snRNA and
APDH gene were amplified using the following oligonucleotides:
1, forward primer 5#-CCTGCGATTTCCCCAAATG-3# and reverse
rimer 5#-GATATGACCCTTAGCGTACAG-3#; U2, forward primer
#-CTGATACGTCCTCTATCCGAGGAC-3# and reverse primer 5#-CAA
CCGCCCCGCAGGTGCTAC-3#; GAPDH, forward primer 5#-GGA
GAGAGAGACCCTCACTGC-3# and reverse primer 5#-CCTTGA
ACAAGCCCAGCTTCC-3#. PCR products were cloned into pCRII-
OPO (Invitrogen).
eneration of GST-CTD Fusion Protein
he GST-CTD fusion protein was expressed in Escherichia coli
L21 (DE3) and purified over glutathione-coupled resin (Pharmacia)
s described (Naar et al., 2002).
urification of CTD Binding Polypeptides
eLa nuclear extract (100 ml) was applied to a 50 ml P11 phospho-
ellulose (PC) column pre-equilibrated with 0.1 M KCl HEG (20 mM
EPES [pH 7.6], 0.1 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM
enzamidine, 0.25 mM PMSF, 2 g/ml aprotinin). The column was
tep eluted using two column volumes of 0.3 M, 0.5 M, and 1.0 M
Cl HEG. The fractions were then dialyzed to 0.1 M KCl. Large-
cale purification of GST-CTD binding polypeptides was achieved
y incubating 50 ml of the PC 0.5 M or 1 M fractions (precleared
ith GST beads twice for 1 hr) with 1 ml of GST-CTD-coupled
eads for 3 hr nutating at 4°C. The beads were washed with 7 × 15
l of 0.5 M KCl HEG plus 0.1% NP40 (HEGN) followed by two
ashes with 0.1 M KCl HEGN. Bound proteins were eluted by incu-
ating twice with 0.5 ml of 0.3% sarkosyl in 0.1 M KCl HEGN for 1
r nutating at 4°C. The eluted material was analyzed using SDS-
AGE and silver staining.
TD Binding Polypeptide Microsequencing
oncentrated GST-CTD-purified proteins were separated by SDS-
AGE and transferred to a PVDF membrane. After Ponceau S stain-
ng, the bands were excised and subjected to trypsin digestion fol-
owed by HPLC separation of peptides. The purified peptides were
hen analyzed by microsequencing, and sequences were used to
earch the GenBank database using the BLAST program.
n Vitro Transcription Assay
n vitro transcription assays were carried out using an AdML pro-
oter and purified transcription factors as previously described
Gerber et al., 2001). Transcriptional activity of increasing amounts
f Integrator complex was compared with that of RNA polymerase
I purified from HeLa cell nuclear extract.
iRNA Transfections
iRNAs were purchased from Dharmacon, Inc. The Int1 siRNA se-
uences were (1) AA-UGAGGAUCCUGCAUAUGGA and (2) AA-GAA
CGACCUGAACUGUCA. The Int11 siRNA sequence was AA-
GACCGAUGGUUGUGUUUUG. The control siRNA sequence, cor-
esponding to firefly luciferase, was AA-CGUACGCGGAAUACUU
GA. siRNA transfections were performed with HeLa cells using
A Novel RNA Polymerase II Complex
275Lipofectamine 2000 (Life Technologies, Inc.) according to manufac-
turer’s instructions, using a final concentration of 80 nM siRNA in
the culture medium. Cells were harvested 48 to 72 hr after trans-
fection.
Site-Directed Mutagenesis
E203Q mutation in Int11 was introduced using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). The sequence of the
upper-strand oligonucleotide used was 5#-CCTGCTCATCACACA
GTCCACGTACGCCAC-3#.
RNA Synthesis
RNA probes, internally labeled with [α-32P]CTP, were transcribed
using T7 RNA polymerase (Riboprobe System, Promega). U1 or U2
DNA templates were generated by PCR from the U1 and U2 pCRII-
TOPO plasmids (see Plasmid Constructs) using M13 reverse primer
(Invitrogen) and U1 forward primer 5#-CCTGCGATTTCCCCAAATG-3#
or U2 forward primer 5#-CTGATACGTCCTCTATCCGAGGAC-3#, re-
spectively. GAPDH template was generated the same way using
M13 forward and M13 reverse primers. After synthesis, RNA probes
were purified by 6% polyacrylamide-7 M urea gel electrophoresis
and extracted after 2 hr at 65°C in elution buffer (RPA III kit,
Ambion).
Ribonuclease Protection Assay
Total RNAs were extracted from siRNA-treated HeLa cells using
Trizol Reagent (Invitrogen). After purification, RNAs were further
treated with 10 units of RNase-free DNase I (Roche), phenol/chloro-
form extracted and ethanol precipitated. Ribonuclease protection
assays were performed using RNase T1 (RPA III kit, Ambion) ac-
cording to manufacturer’s recommendations. Ten micrograms of
total RNA were used for each reaction. Hybridizations were per-
formed overnight at 42°C, and RNA hybrids were digested 30 min
at 37°C with RNase T1 (1/50 dilution). Protected fragments were
resolved by 6% polyacrylamide-7 M urea gel electrophoresis. Gels
were transferred to Whatman paper, dried, and autoradiographed,
and band intensities were quantified using a phosphorimager.
RT-PCR
cDNAs were synthesized from 2 g of total RNA using random
primers and Superscript II reverse transcriptase (First-Strand Syn-
thesis System, Invitrogen) at 42°C for 50 min. cDNAs were detected
by PCR using the following primers: GAPDH (22 cycles), forward
primer 5#-TCTGCCCCCTCTGCTGATGC-3#, reverse primer 5#-TTC
TGGGTGGCAGTGATGGC-3#; Int1 (30 cycles), forward primer 5#-
GGACAAGAATTACATGGCCC-3#, reverse primer 5#-CTTTGGTTT
GGGTGCCTCTG-3#; Int11 (30 cycles), forward primer 5#-ACC
CAGGCCATCTGCCCCATCTTGC-3#, reverse primer 5#-GGCGGC
ACTTGTCAATCCAGGCAGC-3#. PCR products were resolved by
2% agarose gel electrophoresis and visualized with ethidium bro-
mide (Sigma) under UV illumination.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed by
using a modified protocol from Upstate Biotechnology. Cells in a
10 cm dish were fixed at 37°C for 10 min with 1% formaldehyde.
After crosslinking, cells were washed, harvested, and resuspended
in 300 l SDS lysis buffer and sonicated under conditions yielding
fragments ranging from 200 to 1000 bp. Samples were diluted ten
times with ChIP dilution buffer and precleared for 2 hr at 4°C with
recombinant protein A agarose beads (Repligen) coated with BSA,
salmon-sperm DNA, and tRNA. Precleared lysates were used for
an overnight immunoprecipitation using 5 g (IgG or M2) or 10 l
(8WG16 ascites) of specific antibodies at 4°C. Complexes were col-
lected for 1 hr using recombinant protein A agarose beads (Repli-
gen) coated with BSA, salmon-sperm DNA, and tRNA. After wash-
ing, complexes were eluted for 1 hr at room temperature in elution
buffer (1% SDS, 0.1 M NaHCO3), and formaldehyde crosslinking
was reversed overnight at 65°C. Eluted DNA was recovered
through QIAquick columns (QIAGEN) and used as a template for
PCR. The PCR primer sequences are the following: U1-A, forward
primer 5#-GGAAGTGAGAATCCCAGCTG-5#, reverse primer 5#-CCC
TGCCAGGTAAGTATGAG-3#; U1-B, forward primer 5#-CGTACGCCAAGGGTCATGTC-3#, reverse primer 5#-CGTCGCTTTTTCTCCTAT
GGC-3#; U2-A, forward primer 5#-TGTAAGGGCGTCAATAGCGC-3#,
reverse primer 5#-TAGCCAAAGGCCGAGAAGC-3#; U2-B, forward
primer 5#-GGGAGGTGAGAGACGGTAGC-3#, reverse primer 5#-CGC
ACATCAGGAACCTCACG-3#; GAPDH-5#, forward primer 5#-CCCGG
TTTCTATAAATTGAGCCCG-3#, reverse primer 5#- GTTTCTCTCCG
CCCGTCTTC-3#; GAPDH-cds, forward primer 5#-GTAAGGAGATGC
TGCATTCG-3#, reverse primer 5#-AGAGGCAAGAAGGCATGAGG-3#;
GAPDH-3#, forward primer 5#-GCCATGTAGACCCCTTGAAG-3#, re-
verse primer 5#-CCCAGACCCTAGAATAAGAC-3#, cell-cycle-depen-
dent histone H3, forward primer 5#-GCGGTGATGGCGCTGCAGG
AGGC-3#, reverse primer 5#-GCGAGCTGGATGTCTTTGGGCAT-3#.
Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/cgi/content/full/123/2/265/
DC1/.
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